Global Fertility Tourism Market 2024-2031

Global Fertility Tourism Market 2024-2031

Fertility Tourism Market Size, Share & Trends Analysis Report By Service (In Vitro Fertilization (IVF) Services, Egg Donation Services, Sperm Donation Services, Surrogacy Services, and Others), by Age (Below 28 Years, 28-34 Years, and Above 35 Years), and by End-User (Female, and Male) Forecast Period (2024-2031)

Fertility tourism market is anticipated to grow at a CAGR of 12.6% during the forecast period (2024-2031). The global fertility tourism market is expanding owing to several factors, including cost efficiency, advanced medical technology, favorable regulatory environments, cultural compatibility, and accessibility. Patients from around the world are choosing countries such as India, Thailand, and Spain for affordable fertility treatments, while others seek well-established clinics with advanced technologies. Shorter waiting times and increased accessibility to clinics and specialists are highly valued by patients seeking timely treatment, and considerations for privacy and confidentiality are also considered.

Market Dynamics

Increasing Demand for Fertility Treatments

Infertility burden drives global demand for fertility treatments. According to the World Health Organization, in June 2022, approximately 60 to 80 million couples globally face infertility challenges, with Southern and Eastern Europe as well as East Asia exhibiting some of the lowest fertility rates, averaging at 1.5 children per woman. Additionally, it is estimated that 1 in 4 couples in developing countries experience difficulties conceiving. Over the years, assisted reproductive technology (ART) has seen an annual increase of 5.0% to 10.0% based on available data.

Growing Awareness of Fertility Treatments

The utilization of advanced medical technology and specialized medical expertise attracts patients globally. For instance, in February 2023, Bumrungrad International Hospital launched a Fertility Center & IVF Clinic to address the issue of infertility in Thailand. The clinic offers holistic reproductive care, including consultations and assisted technology, to help families conceive. The clinic additionally provides a Neonatal Intensive Care Unit (NICU) team to ensure healthy pregnancy and safe delivery. The hospital recognizes the importance of building a family and is committed to addressing the population decline problem.

Market Segmentation

Based on service, the market is segmented into in vitro fertilization (IVF) services, egg donation services, sperm donation services, surrogacy services, and others (fertility medications and hormonal treatments).

Based on age group, the market is segmented into below 28 years, 28-34 years, and above 35 years.

Based on the end-user, the market is segmented into female and male.

In Vitro Fertilization (IVF) Services Sub-segment to Hold a Considerable Market Share

The primary factor supporting the segment's growth includes the growing efficiency of IVF with technological improvements and ongoing treatment protocol innovations. According to the Human Fertilisation and Embryology Authority (HFEA), in March 2024, the UK fertility regulator HFEA reported over 1.3 million IVF and 260,000 DI cycles have been performed since 1991, resulting in 390,000 babies. Advances in technology and treatment have improved birth rates for patients under 43, with the multiple birth rate at its lowest ever at 6.0% in 2019, exceeding the HFEA target of 10%.

Regional Outlook

The fertility tourism market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).

Growing Compatibility of Language and Culture in Europe Region

International fertility clinics provide multilingual staff and culturally sensitive care, rendering the environment acceptable to patients seeking treatment internationally. For instance, in July 2023, Béa Fertility offered an at-home fertility kit for those seeking an alternative to IVF and IUI procedures. The kit allows users to perform intracervical insemination without hormone injections. It includes ovulation and pregnancy tests, a fertility library, a treatment app, and live support. The company raised £2.5 million ($3.2 million) for its UK launch, with a three-month treatment costing £700 ($885.4 million), one-twentieth of IVF treatment.

Asia-Pacific Holds Major Market Share

The availability of legal and regulatory environments on fertility treatments and third-party reproduction in specific countries such as India, and China motivates individuals to seek treatment overseas. For instance, in October 2020, Nova IVF Fertility launched a new state-of-the-art IVF center in Patna. With a legacy spanning 10 years in the field of assisted reproductive therapy & over 35000 IVF pregnancies, Nova IVF brings in the most advanced fertility treatment to Eastern India. The center offers a range of fertility solutions, including IVF Specialists, trained embryologists, and a modern Embryology Lab, all backed by global standards and protocols. Further, in July 2023, Victoria opened Australia's first public egg and sperm bank, offering free donations to eligible Victorians. The bank, located at the Royal Women's Hospital, is part of a $120.0 million initiative that includes public fertility services, IVF treatments, diagnostic tests, and counseling. Additionally, the program enables Victorians to receive medical treatment to preserve the course of sperm or eggs.

Market Players Outlook

The major companies serving the fertility tourism market include Apollo Specialty Hospitals Pvt. Ltd., Bourn Hall Ltd., Manchester Fertility Services Ltd, San Diego Fertility Center, and The Fertility Partners Inc. among others. The market players are increasingly focusing on business expansion and product development by applying strategies such as collaborations, mergers and acquisitions to stay competitive in the market. For instance, in May 2024, Birla Fertility & IVF acquired an 86.0% stake in ARMC IVF, a Kerala-based fertility center chain, marking its entry into southern India. The acquisition aims to expand its footprint to 100 clinics by FY28, with an investment exceeding ₹500 crore ($60 million).